OB
Olivia Brayer Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $230 |
35%
upside
| 1 | -14% |
0
%
| 16 Dec ‘25 23 days ago |
|
|
|
Overweight
Initiated
| $4 |
140%
upside
| 1 | +13% |
0
%
| 11 Dec ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $11 |
50%
upside
| 2 | +36% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $6 |
41%
upside
| 1 | +115% |
0
%
| 22 Sep ‘25 3 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -20% |
0
%
| 11 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $525 |
7%
upside
| 2 | +24% |
0
%
| 10 Sep ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $100 | – | 1 | +23% |
0
%
| 11 Jun ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $90 |
49%
upside
| 1 | -8% |
0
%
| 20 Feb ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| $480 |
2%
upside
| 3 | +2.3% |
0
%
| 11 Feb ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $55 |
2%
downside
| 1 | – |
–
| 4 Feb ‘25 11 months ago |
|